PHGE - BiomX Inc.
0.58
-0.006 -1.000%
Share volume: 159,794
Last Updated: 04-04-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$0.59
-0.01
-0.01%
View ratios
Fiscal Date | 09-30-2024 | 12-31-2024 | |
---|---|---|---|
Fiscal Quarter | Q3 2024 | Q4 2024 | |
Report Date | 11-14-2024 | 03-25-2025 | |
Total revenue | 20.643 M | -39.756 M | |
Cost of revenue | 0.000 | 0.000 | |
Gross profit | 0.000 | 0.000 | |
Operating expenses | 0.000 | 0.000 | |
Selling general and admin | 0.000 | 0.000 | |
Research and development | 0.000 | 0.000 | |
Total expenses | 0.000 | 0.000 | |
Operating income | 0.000 | 0.000 | |
Ebit | 9.310 M | -49.163 M | |
Pretax income | 9.642 M | -14.510 M | |
-250.49% | |||
Income tax | 0.000 | 3.000 K | |
Net income basic | 0.000 | 0.000 | |
Net income | 9.642 M | -14.513 M | |
-250.52% |